Abstract
Sex determination in mammals depends on the differentiation of the supporting lineage of the gonads into Sertoli or pregranulosa cells that govern testis and ovary development, respectively. Although the Y-linked testis-determining gene Sry has been identified, the ovarian-determining factor remains unknown. In this study, we identified −KTS, a major, alternatively spliced isoform of the Wilms tumor suppressor WT1, as a key determinant of female sex determination. Loss of −KTS variants blocked gonadal differentiation in mice, whereas increased expression, as found in Frasier syndrome, induced precocious differentiation of ovaries independently of their genetic sex. In XY embryos, this antagonized Sry expression, resulting in male-to-female sex reversal. Our results identify −KTS as an ovarian-determining factor and demonstrate that its time of activation is critical in gonadal sex differentiation.
Original language | English |
---|---|
Pages (from-to) | 600-605 |
Number of pages | 6 |
Journal | Science |
Volume | 382 |
Issue number | 6670 |
DOIs | |
State | Published - 3 Nov 2023 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2023 American Association for the Advancement of Science. All rights reserved.
Funding
This research was supported by Agence Nationale de la Recherche grant ANR-19-CE14-0022 SexDiff (M.-C.C.), Fondation Maladies Rares grant FONDATION-GenOmics 2018-1 181003 RNAseq (M.-C.C.), Agence Nationale de la Recherche grant ANR-20-CE14-0022 Ardigerm (M.-C.C.), and Swiss National Science Foundation grants 31003A_173070 (S.N.) and 310030_200316 (S.N.). The Francis Crick Institute receives its core funding from Cancer Research UK (FC001107), the UK Medical Research Council (FC001107), Wellcome (FC001107), and the UK Medical Research Council (U117512772) (R.M., M.L.S., and R.L.-B.).
Funders | Funder number |
---|---|
Wellcome Trust | U117512772 |
Fondation Maladies Rares | FONDATION-GenOmics 2018-1 181003, ANR-20-CE14-0022 |
Medical Research Council | |
Cancer Research UK | FC001107 |
Agence Nationale de la Recherche | ANR-19-CE14-0022 |
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung | 310030_200316, 31003A_173070 |